Toxicology and Pharmacological Interactions of Classic Psychedelics.
Current Topics in Behavioral Neurosciences July 24, 2024 DOI: 10.1007/7854_2024_508 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Drug safety toxicology Adverse effects Drug–drug interactions Psychedelics hallucinogens Biotransformation Entheogens Medication interactions Metabolism pharmacokinetics Therapeutic use clinical |
| Citations | 3 |
| Key findings | The chapter summarizes the known toxicology and drug-drug interactions for several classic psychedelics. |
Abstract
As psychedelics are being investigated for more medical indications, it has become important to characterize the adverse effects and pharmacological interactions with these medications. This chapter will summarize what is known about the toxicology and drug-drug interactions for classic psychedelics, such as LSD, psilocybin, DMT, 5-MeO-DMT, mescaline, 2C-B, Bromo-DragonFLY, and 25X-NBOMe.
Citations in the library
Cited by 3
- Psychedelics as Novel Therapeutics for Chronic Pain in Veterinary Medicine: A Hypothesis-Driven Protocol Using Low-Dose 1-Cyclopropionyl-D-lysergic Acid Diethylamide (1cp-LSD) in Canine Osteoarthritis. Animals : an open access journal from MDPI December 19, 2025
- Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil. Journal of Psychoactive Drugs March 20, 2026
- Eligibility for psychedelic therapy: Clinical trial medical exclusion criteria and their implications for hospital practice. General Hospital Psychiatry 2026
Cites 53
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Neuropsychopharmacology January 26, 2019
- Human psychopharmacology of N,N-dimethyltryptamine Behavioural Brain Research December 1, 1995
- Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects Neuropsychopharmacology October 15, 2020
- Harm potential of magic mushroom use: a review. Regulatory toxicology and pharmacology : RTP April 1, 2011
and 48 more in the library